P
Philip D. Gregory
Researcher at Sangamo BioSciences
Publications - 190
Citations - 37412
Philip D. Gregory is an academic researcher from Sangamo BioSciences. The author has contributed to research in topics: Zinc finger nuclease & Zinc finger. The author has an hindex of 76, co-authored 188 publications receiving 34664 citations. Previous affiliations of Philip D. Gregory include Vita-Salute San Raffaele University & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
A TALE nuclease architecture for efficient genome editing
Jeffrey C. Miller,Siyuan Tan,Guijuan Qiao,Kyle A. Barlow,Jianbin Wang,Danny F Xia,Xiangdong Meng,David Paschon,Elo Leung,Sarah J. Hinkley,Gladys P Dulay,Kevin Hua,Irina Ankoudinova,Gregory J. Cost,Fyodor D. Urnov,H. Steve Zhang,Michael C. Holmes,Lei Zhang,Philip D. Gregory,Edward J. Rebar +19 more
TL;DR: This study identifies TALE truncation variants that efficiently cleave DNA when linked to the catalytic domain of FokI and uses them to generate discrete edits or small deletions within endogenous human NTF3 and CCR5 genes at efficiencies of up to 25%.
Journal ArticleDOI
Genome editing with engineered zinc finger nucleases
TL;DR: A broad range of outcomes has resulted from the application of the same core technology: targeted genome cleavage by engineered, sequence-specific zinc finger nucleases followed by gene modification during subsequent repair.
Journal ArticleDOI
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
Fyodor D. Urnov,Jeffrey C. Miller,Ya-Li Lee,Christian Beauséjour,Jeremy M. Rock,Sheldon Augustus,Andrew C. Jamieson,Matthew H. Porteus,Philip D. Gregory,Michael C. Holmes +9 more
TL;DR: It is shown that zinc-finger nucleases designed against an X-linked severe combined immune deficiency mutation in the IL2Rγ gene yielded more than 18% gene-modified human cells without selection, raising the possibility of strategies based on zinc- finger nucleases for the treatment of disease.
Journal ArticleDOI
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.
Pablo Tebas,David Stein,Winson Tang,Ian Frank,Shelley Wang,Gary Lee,S. Kaye Spratt,Richard T. Surosky,Martin Giedlin,Geoff Nichol,Michael C. Holmes,Philip D. Gregory,Dale G. Ando,Michael Kalos,Ronald G. Collman,Gwendolyn Binder-Scholl,Gabriela Plesa,Wei-Ting Hwang,Bruce L. Levine,Carl H. June +19 more
TL;DR: CCR5-modified autologous CD4 T-cell infusions are safe within the limits of this study, and HIV RNA became undetectable in one of four patients who could be evaluated.
Journal ArticleDOI
Genetic engineering of human pluripotent cells using TALE nucleases
Dirk Hockemeyer,Haoyi Wang,Samira Kiani,Christine S. Lai,Qing Gao,John P. Cassady,Gregory J. Cost,Lei Zhang,Yolanda Santiago,Jeffrey C. Miller,Bryan Zeitler,Jennifer M. Cherone,Xiangdong Meng,Sarah J. Hinkley,Edward J. Rebar,Philip D. Gregory,Fyodor D. Urnov,Rudolf Jaenisch +17 more
TL;DR: In this article, the authors used transcription activator-like effector nucleases (TALENs) for site-specific genome modification in human pluripotent cells with similar efficiency and precision as do zinc-finger nucleases.